Beyond Chemotherapy: Barrier Biology in MF-CTCL - European Medical Journal

This site is intended for healthcare professionals

Beyond Chemotherapy: Barrier Biology in MF-CTCL

Oncology

The content of this video is based on a non-promotional symposium. The symposium and publication of this content were made possible by the contribution of Helsinn Healthcare SA.


 

Speakers:

Christiane Querfeld1

Robert Rissmann2

Emmanuella Guenova3

1. Director of the Cutaneous Lymphoma Program at City of Hope, USA. A leading dermatologist and dermatopathologist, she specialises in the diagnosis, treatment, and research of cutaneous lymphomas.
2. Professor of Translational Dermatology at Leiden University and Research Director at CHDR, Netherlands. His work focuses on skin pharmacology, translational dermatology, and early-phase clinical research.
3. Chair of Translational Immunodermatology at Johannes Kepler University, Austria, and an internationally recognised expert in immunodermatology, precision dermatology, and cutaneous lymphomas.

Rate this content's potential impact on patient outcomes

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this content.